{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:35:30Z","timestamp":1793795730213,"version":"4.6.1"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1001\/jamaneurol.2022.0829","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T15:01:33Z","timestamp":1651503693000},"page":"554","source":"Crossref","is-referenced-by-count":136,"title":["Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome"],"prefix":"10.1001","volume":"79","author":[{"given":"Kelly G.","family":"Knupp","sequence":"first","affiliation":[{"name":"Department of Neurology, Children\u2019s Hospital Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Scheffer","sequence":"additional","affiliation":[{"name":"Austin Hospital and Royal Children\u2019s Hospital, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berten","family":"Ceulemans","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Weill Institute for Neurosciences, Benioff Children\u2019s Hospital, University of California San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Nickels","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[{"name":"Steering Committee, European Reference Network EpiCARE, Lyon, France"},{"name":"Department of Paediatric Neurology, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[{"name":"Pediatric Neurology and Neurogenetics Unit, Anna Meyer Children\u2019s Hospital, University of Florence, Florence, Italy"},{"name":"Neurobiologia e Neurogenetica dei Disturbi del Neurosviluppo, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer M.","family":"Zuberi","sequence":"additional","affiliation":[{"name":"Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker-Enfants Malades Hospital, Imagine Institute, University Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Riney","sequence":"additional","affiliation":[{"name":"Neuroscience Unit, Queensland Children\u2019s Hospital, South Brisbane, Queensland, Australia"},{"name":"School of Clinical Medicine, University of Queensland, St Lucia, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Shore","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"},{"name":"Now with Neurocrine Biosciences, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lock","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"},{"name":"Now with Zogenix Inc, Haiku, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail M.","family":"Farfel","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S.","family":"Galer","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold R.","family":"Gammaitoni","sequence":"additional","affiliation":[{"name":"Zogenix Inc, Emeryville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Davis","sequence":"additional","affiliation":[{"name":"Neurology and Epilepsy Research Center, Orlando, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gil-Nagel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Epilepsy Program, Hospital Ruber Internacional, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi220015r1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fneur.2017.00505","article-title":"Expert opinion on the management of Lennox-Gastaut syndrome: treatment algorithms and practical considerations.","volume":"8","author":"Cross","year":"2017","journal-title":"Front Neurol"},{"issue":"2","key":"noi220015r2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/epi.1966.7.issue-2","article-title":"Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as \u201cpetit mal variant\u201d) or Lennox syndrome.","volume":"7","author":"Gastraut","year":"1966","journal-title":"Epilepsia"},{"issue":"1","key":"noi220015r3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","article-title":"Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.","volume":"8","author":"Arzimanoglou","year":"2009","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi220015r4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/1817-1745.159184","article-title":"Relationship of Lennox-Gastaut syndrome with perinatal event: a cross-sectional study.","volume":"10","author":"Kumar","year":"2015","journal-title":"J Pediatr Neurosci"},{"key":"noi220015r5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ebcr.2016.01.004","article-title":"Challenges in identifying Lennox-Gastaut syndrome in adults: a case series illustrating its changing nature.","volume":"5","author":"Pi\u00f1a-Garza","year":"2016","journal-title":"Epilepsy Behav Case Rep"},{"key":"noi220015r6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/epi.2009.50.issue-s8","article-title":"Dravet syndrome: from electroclinical characteristics to molecular biology.","volume":"50","author":"Arzimanoglou","year":"2009","journal-title":"Epilepsia"},{"key":"noi220015r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107647","article-title":"Epidemiology, healthcare resource use, and mortality in patients with probable Lennox-Gastaut syndrome: a population-based study on German health insurance data.","volume":"115","author":"Strzelczyk","year":"2021","journal-title":"Epilepsy Behav"},{"key":"noi220015r8","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1684\/epd.2011.0422","article-title":"All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome... but many do.","volume":"13","author":"Arzimanoglou","year":"2011","journal-title":"Epileptic Disord"},{"issue":"4","key":"noi220015r9","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1212\/WNL.0000000000008741","article-title":"Clinical risk factors in SUDEP: a nationwide population-based case-control study.","volume":"94","author":"Sveinsson","year":"2020","journal-title":"Neurology"},{"issue":"20","key":"noi220015r10","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome.","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"10125","key":"noi220015r12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a andomized, double-blind, placebo-controlled phase 3 trial.","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"noi220015r14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment-resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens: a randomized clinical trial.","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10216","key":"noi220015r15","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a andomized, double-blind, placebo-controlled trial.","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"noi220015r16","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/epi.14540","article-title":"A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome.","volume":"59","author":"Lagae","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"noi220015r17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/epi.v61.11","article-title":"Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: analysis of an ongoing long-term open-label safety extension study.","volume":"61","author":"Lai","year":"2020","journal-title":"Epilepsia"},{"issue":"15","key":"noi220015r18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","article-title":"Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome.","volume":"77","author":"Ng","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"noi220015r19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10072-017-3188-y","article-title":"Lennox-Gastaut syndrome: a comprehensive review.","volume":"39","author":"Asadi-Pooya","year":"2018","journal-title":"Neurol Sci"},{"key":"noi220015r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.106989","article-title":"Fenfluramine acts as a positive modulator of sigma-1 receptors.","volume":"105","author":"Martin","year":"2020","journal-title":"Epilepsy Behav"},{"key":"noi220015r22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fphar.2017.00191","article-title":"Pharmacological analysis of the anti-epileptic mechanisms of fenfluramine in scn1a mutant zebrafish.","volume":"8","author":"Sourbron","year":"2017","journal-title":"Front Pharmacol"},{"issue":"16","key":"noi220015r23","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.3390\/ijms22168416","article-title":"An emerging role for sigma-1 receptors in the treatment of developmental and epileptic encephalopathies.","volume":"22","author":"Martin","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"pt A","key":"noi220015r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108024","article-title":"Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: analysis from a phase 3 long-term extension study in children\/young adults with Dravet syndrome.","volume":"121","author":"Bishop","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"11","key":"noi220015r27","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1111\/epi.v61.11","article-title":"Fenfluramine HCl (Fintepla\u00ae) provides long-term clinically meaningful reduction in seizure frequency: analysis of an ongoing open-label extension study.","volume":"61","author":"Sullivan","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"noi220015r28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"},{"key":"noi220015r29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.seizure.2021.08.005","article-title":"Cluster analysis of a large dataset of patients with Lennox-Gastaut syndrome.","volume":"92","author":"Asadi-Pooya","year":"2021","journal-title":"Seizure"},{"issue":"2","key":"noi220015r30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1212\/WNL.0000000000004094","article-title":"The incidence of SUDEP: a nationwide population-based cohort study.","volume":"89","author":"Sveinsson","year":"2017","journal-title":"Neurology"},{"key":"noi220015r31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.seizure.2021.10.024","article-title":"Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndrome.","volume":"93","author":"Cross","year":"2021","journal-title":"Seizure"},{"key":"noi220015r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108212","article-title":"Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.","volume":"122","author":"Gil-Nagel","year":"2021","journal-title":"Epilepsy Behav"},{"key":"noi220015r11","author":"Hahn","year":"2020"},{"key":"noi220015r13","author":"Sullivan","year":"2020"},{"key":"noi220015r20","volume-title":"Lennox Gastaut Syndrome: StatPearls","author":"Amrutkar","year":"2021"},{"key":"noi220015r25","author":"Bishop"},{"key":"noi220015r26","author":"Scheffer","year":"2020"},{"key":"noi220015r33","author":"Agarwal","year":"2021"},{"key":"noi220015r34","author":"Knupp","year":"2021"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2791918\/jamaneurology_knupp_2022_oi_220015_1653667079.68349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T15:13:28Z","timestamp":1655133208000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2791918"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2022.0829","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}